Teplitsky Liane Rae purchased $100K of PLSE
Teplitsky Liane Rae (Chief Operating Officer) purchased 2,070 shares of PULSE BIOSCIENCES, INC. (PLSE) at an average of $48.29 ($48.24–$48.35) across 2 trades over 2026-08-26 to 2026-08-28.
How this was made
The 30-second read
Why it matters
The disclosed purchase is modest and unlikely to move the stock significantly, but it adds to the insider activity record.
Market read
Limited relevance; adds a data point to insider activity monitoring.
What to watch
Potential upcoming clinical trial milestones that may have prompted the insider to increase stake.
Background
Form 4 filings disclose insider transactions; investors monitor them for signals of insider confidence.
Ticker impact
COO Teplitsky Liane Rae bought 2,070 shares of Pulse Biosciences for $99,965, a direct insider purchase disclosed on Form 4.
Minor upward pressure, likely within normal volatility range.
Purchase amount is under $100k and represents a tiny fraction of float; while insider buying is positive, the scale does not suggest a material shift.
Market effects
Minimal effect on biotech sector; typical insider activity.
No regional impact.
Not globally relevant.
Counterpoint
The purchase could be a routine compensation exercise rather than a confidence signal.
Key entities
- CompanyPulse Biosciences, Inc.
Biotech firm developing cell-based therapies.
- PersonTeplitsky Liane Rae
Chief Operating Officer of Pulse Biosciences.
